About.

Supreme Heights targets investments in high quality, differentiated brands with defendable business models and strong management teams in the UK and European branded CBD health & wellness segment. Our aim is to support the local UK and European businesses that embrace our core values of sustainability, innovation and community.

Strategic Partner

Supreme Heights works collaboratively with The Supreme Cannabis Company, Inc. to diligently assess investment opportunities, identify synergies and advance the businesses in its portfolio.

Health & Wellness Brands

We specialize in compounds such as cannabidiol (CBD) and other plant-based products that are fully legal and have demonstrated the tremendous potential to assist overall health and wellness.

High-Growth Opportunities

We invest in the UK and Europe’s CBD space, providing capital and guidance to help grow early-stage entrepreneurial companies developing high quality, innovative products.

Team.

Patrick Morton, CEO

Patrick Morton is the co-founder of Cannabis Invest UK, which hosts the largest professional cannabis investment conference in the UK and Europe, having featured $50 billion of presenting companies. Prior to joining the cannabis industry in 2017, Patrick spent 13 years in the capital markets industry, primarily as an equity research analyst on top-ranked teams with RBC Capital Markets and the Macquarie Group. Patrick is a CFA Charter holder and holds a BComm from McGill University.


 

Navdeep Dhaliwal, Chairman

Navdeep Dhaliwal is the CEO and a Director of The Supreme Cannabis Company, Inc. Mr. Dhaliwal is also a Director of Medigrow Lesotho, a Licensed Producer in the Kingdom of Lesotho. Mr. Dhaliwal was previously the Principal of NLX Capital Corp., a Canadian merchant bank and venture investment firm, and Vice President of corporate development for Novalux Energy Corporation. Mr. Dhaliwal began his career with KPMG LLP, where he specialized in financial institutions and real estate.


 

Scott Walters, Director

Scott Walters is the Vice President of Corporate Development at Supreme Cannabis. Since 2013, Mr. Walters has been focused on developing and commercializing positive-impact businesses in the Canadian medical cannabis sector. Mr. Walters is the founder and former CEO of Molecular Science Corporation. Previously, he was a co-founder of THC BioMed, Canabo Medical and Empower Clinics, one of the fastest growing medical cannabis clinic networks in the U.S. Pacific Northwest.


 

Peter Cunningham, Senior Advisor

Peter has been involved in more than USD $100 million in financings for projects spanning multiple industries. Peter has advised over a dozen gopublic transactions during his career, including G-TEC (TSXV: GTEC), Khiron Life Sciences Corp. (TSX:KHRN), High Hampton Holdings Corp (CNSX: HC); and BeWhere (TSXV: BEW) amongst others. Peter has over 10 years of experience in the capital markets and is a sought-after corporate advisor and investor.


 

Riyaz Lalani, Director

Riyaz is the CCO of Supreme Cannabis. Over the last two decades, Mr. Lalani has advised public companies, boards of directors, private equity funds and hedge funds across North America. Prior to founding Bayfield Strategy Inc., a leading communications and stakeholder relations firm, Mr. Lalani was the Chief Operating Officer of a leading shareholder services firm in Canada. Beforehand, he was the head of research for an international asset manager in New York and Toronto.


 

Nick Davis, Director

Nick Davis is the Chief Executive Officer of Memery Crystal, one of the UK’s leading law firms in specialist areas, regularly cited in Chambers UK and The Legal 500, and a market leader in the UK cannabis sector. Nick specializes in corporate finance with expertise in flotations, equity capital markets and mergers & acquisitions. Nick advises on public company listings on both the Main Market and AIM and has extensive experience acting for other issuers, NOMAD/brokers and sponsors.


 

Contact.

Supreme Heights
165 Fleet Street
London, UK
EC4A 2DY